Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin ...

Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...

Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business ...

President-elect Donald Trump set two tables for a dinner party this month with his choice for Health and Human Services ...

Cowboy boots, an Ohio River scene, former First Dog Henry: all were key components of outgoing Indiana Gov. Eric Holcomb’s ...

ORLANDO -- A considerable amount of variability exists in surgical management of ileosigmoid fistulas in Crohn's disease (CD) ...

A subgroup analysis showed that the benefit in high-risk patients was limited to those with tumors >2 cm, reported Nan Chen, MD, of the University of Chicago, at the San Antonio Breast Cancer ...

T-DXd outperformed physician’s choice of chemotherapy regardless of patients’ disease burden or time to progression on prior therapy.

The Ripley County Community Foundation has announced the recipient of the 2025 Lilly Endowment Community Scholarship for ...